Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 01 04:00PM ET
44.21
Dollar change
+0.27
Percentage change
0.61
%
IndexS&P 500 P/E- EPS (ttm)-3.10 Insider Own0.08% Shs Outstand2.03B Perf Week-9.52%
Market Cap89.62B Forward P/E6.37 EPS next Y6.94 Insider Trans0.84% Shs Float2.03B Perf Month-16.17%
Income-6148.00M PEG- EPS next Q1.68 Inst Own78.38% Short Float1.70% Perf Quarter-9.54%
Sales45.53B P/S1.97 EPS this Y-92.88% Inst Trans-0.74% Short Ratio2.11 Perf Half Y-13.74%
Book/sh8.14 P/B5.43 EPS next Y1198.35% ROA-6.36% Short Interest34.36M Perf Year-35.37%
Cash/sh4.77 P/C9.27 EPS next 5Y-4.17% ROE-25.45% 52W Range43.93 - 69.10 Perf YTD-13.84%
Dividend Est.2.41 (5.45%) P/FCF7.16 EPS past 5Y5.14% ROI-9.10% 52W High-36.02% Beta0.44
Dividend TTM2.34 (5.29%) Quick Ratio0.99 Sales past 5Y16.92% Gross Margin55.85% 52W Low0.64% ATR (14)1.05
Dividend Ex-DateApr 04, 2024 Current Ratio1.11 EPS Y/Y TTM-189.43% Oper. Margin16.55% RSI (14)24.54 Volatility2.97% 1.90%
Employees34100 Debt/Eq3.48 Sales Y/Y TTM-0.68% Profit Margin-13.50% Recom2.64 Target Price53.11
Option/ShortYes / Yes LT Debt/Eq3.10 EPS Q/Q-650.00% Payout59.82% Rel Volume0.81 Prev Close43.94
Sales Surprise3.34% EPS Surprise0.28% Sales Q/Q4.66% EarningsApr 25 BMO Avg Volume16.26M Price44.21
SMA20-9.06% SMA50-12.83% SMA200-18.02% Trades Volume13,244,338 Change0.61%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Downgrade Societe Generale Buy → Hold
Feb-06-24Downgrade Redburn Atlantic Buy → Neutral $77 → $54
Jan-03-24Downgrade BofA Securities Buy → Neutral $68 → $60
Nov-15-23Downgrade Cantor Fitzgerald Overweight → Neutral $68 → $55
Nov-09-23Initiated Deutsche Bank Hold $55
Nov-02-23Downgrade Daiwa Securities Outperform → Neutral $68 → $54
Oct-27-23Upgrade HSBC Securities Reduce → Hold $55 → $53
Oct-27-23Downgrade William Blair Outperform → Mkt Perform
Oct-27-23Downgrade BMO Capital Markets Outperform → Market Perform $60
Oct-20-23Resumed UBS Neutral $70 → $60
May-01-24 08:00AM
Apr-30-24 01:52PM
08:37AM
05:00AM
Apr-29-24 06:00AM
06:59AM Loading…
Apr-26-24 06:59AM
Apr-25-24 04:41PM
03:35PM
02:02PM
01:32PM
11:55AM
11:50AM
11:48AM
11:42AM
09:49AM
06:59AM Loading…
06:59AM
Apr-22-24 01:56PM
06:59AM
Apr-11-24 09:10AM
Apr-08-24 11:30AM
07:00AM
Apr-06-24 08:47PM
01:15PM
01:15PM
Apr-05-24 09:05AM
Apr-02-24 08:08PM
02:30PM
Apr-01-24 07:30AM
Mar-31-24 08:35AM
Mar-29-24 12:09PM
09:45AM Loading…
09:45AM
Mar-28-24 04:05PM
04:01PM
07:30AM
Mar-26-24 07:19AM
06:59AM
Mar-25-24 08:21AM
08:00AM
Mar-21-24 03:00PM
Mar-20-24 04:45PM
08:58AM
06:59AM
Mar-19-24 06:59AM
Mar-18-24 07:32PM
09:52AM
08:44AM
08:00AM
Mar-15-24 06:27PM
12:17PM
Mar-14-24 09:35PM
10:56AM
Mar-13-24 09:03AM
Mar-12-24 08:30AM
Mar-11-24 04:16PM
07:56AM
Mar-07-24 02:23PM
09:10AM
Mar-06-24 04:17PM
Mar-05-24 10:38AM
09:06AM
02:56AM
Mar-04-24 09:06AM
Mar-01-24 04:16PM
Feb-29-24 06:59AM
Feb-28-24 07:34AM
Feb-26-24 04:16PM
08:35AM
Feb-25-24 05:46PM
Feb-24-24 02:31PM
Feb-23-24 06:59AM
06:59AM
Feb-22-24 07:00AM
Feb-20-24 06:59AM
06:30AM
Feb-14-24 07:57PM
04:16PM
08:30AM
06:59AM
Feb-12-24 06:59AM
Feb-07-24 08:55AM
06:59AM
Feb-05-24 09:20AM
06:59AM
Feb-03-24 08:49AM
Feb-02-24 11:37AM
10:58AM
07:26AM
06:59AM
Feb-01-24 05:23PM
09:29AM
05:30AM
Jan-30-24 09:15AM
06:59AM
Jan-27-24 10:00AM
Jan-26-24 07:13AM
Jan-23-24 08:30AM
Jan-22-24 05:05PM
05:00PM
Jan-20-24 10:00AM
Jan-18-24 02:41PM
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shanahan KarinEVP, Glob. Prod. Dev. & SupplyApr 01 '24Option Exercise0.003,30606,532Apr 02 06:45 PM
Lenkowsky AdamEVP, Chief Commercial OfficerMar 10 '24Option Exercise0.0015,016013,859Mar 12 09:54 PM
LEUNG SANDRAEVP, General CounselMar 10 '24Option Exercise0.0046,7840371,312Mar 12 09:43 PM
Plenge Robert MEVP, Chief Research OfficerMar 10 '24Option Exercise0.009,143015,182Mar 12 09:21 PM
Poole Ahn AmandaEVP, Chief Human ResourcesMar 10 '24Option Exercise0.005,45804,841Mar 12 09:11 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Mar 10 '24Option Exercise0.0038,388080,256Mar 12 08:40 PM
Holzer Phil MSVP and ControllerMar 10 '24Option Exercise0.005,520014,916Mar 12 08:31 PM
Hoch LynellePresident, Cell Therapy Org.Mar 10 '24Option Exercise0.004,35103,781Mar 12 08:01 PM
Gallman CariEVP, Corporate AffairsMar 10 '24Option Exercise0.002,76102,655Mar 12 08:00 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerMar 10 '24Option Exercise0.0054,6380129,769Mar 12 07:58 PM
Elkins David VEVP, Chief Financial OfficerMar 10 '24Option Exercise0.0064,3260225,111Mar 12 05:43 PM
Caforio GiovanniExecutive Chair of the BoardMar 10 '24Option Exercise0.00190,1300529,662Mar 12 05:42 PM
Meyers Gregory ScottEVP, Chief Digital & Tech Off.Feb 01 '24Option Exercise0.002,54306,040Feb 05 07:10 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerDec 05 '23Buy49.782,00099,56082,672Dec 07 06:06 PM
Plenge Robert MEVP, Chief Research OfficerDec 02 '23Option Exercise0.0061607,200Dec 05 06:23 PM
Elkins David VEVP, Chief Financial OfficerDec 02 '23Option Exercise0.008,7920172,342Dec 05 06:22 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerDec 02 '23Option Exercise0.002,638082,022Dec 05 06:21 PM
BOERNER CHRISTOPHER S.Chief Executive OfficerNov 28 '23Buy48.863,071150,04979,384Nov 30 06:32 PM
Samuels Theodore R. IIDirectorNov 20 '23Buy49.818,500423,38535,500Nov 21 07:01 PM
Powell AnnEVP, Chief Human ResourcesAug 24 '23Sale61.2517,9861,101,64227,868Aug 28 05:28 PM
Plenge Robert MEVP, Chief Research OfficerAug 03 '23Sale61.1473244,7546,584Aug 07 05:24 PM
Weese MichelleEVP, Corporate AffairsJul 01 '23Option Exercise0.001,88504,135Jul 05 05:26 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Jul 01 '23Option Exercise0.009,357052,032Jul 05 05:23 PM
Lenkowsky AdamEVP, Chief Commercial OfficerJun 03 '23Option Exercise0.001,07701,077Jun 06 07:39 PM
VESSEY RUPERTEVP & President, ResearchMay 03 '23Sale67.0650,3853,378,81847,751May 04 05:51 PM
Last Close
May 01 04:00PM ET
72.25
Dollar change
-0.81
Percentage change
-1.11
%
CNC Centene Corp. daily Stock Chart
IndexS&P 500 P/E14.35 EPS (ttm)5.03 Insider Own1.03% Shs Outstand534.48M Perf Week-5.17%
Market Cap38.56B Forward P/E9.52 EPS next Y7.59 Insider Trans-0.40% Shs Float528.16M Perf Month-0.28%
Income2.73B PEG1.23 EPS next Q1.98 Inst Own95.15% Short Float1.44% Perf Quarter-4.06%
Sales155.52B P/S0.25 EPS this Y2.33% Inst Trans-1.30% Short Ratio2.39 Perf Half Y6.31%
Book/sh50.44 P/B1.43 EPS next Y11.05% ROA3.30% Short Interest7.59M Perf Year5.31%
Cash/sh- P/C- EPS next 5Y11.71% ROE10.52% 52W Range60.83 - 81.42 Perf YTD-2.64%
Dividend Est.- P/FCF14.81 EPS past 5Y17.00% ROI6.10% 52W High-11.26% Beta0.41
Dividend TTM- Quick Ratio- Sales past 5Y21.54% Gross Margin- 52W Low18.77% ATR (14)1.95
Dividend Ex-Date- Current Ratio1.17 EPS Y/Y TTM89.85% Oper. Margin2.27% RSI (14)39.75 Volatility3.17% 2.41%
Employees76000 Debt/Eq0.67 Sales Y/Y TTM6.34% Profit Margin1.76% Recom2.05 Target Price89.50
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q5.94% Payout0.00% Rel Volume1.37 Prev Close73.06
Sales Surprise10.91% EPS Surprise9.50% Sales Q/Q3.90% EarningsApr 26 BMO Avg Volume3.17M Price72.25
SMA20-1.58% SMA50-5.08% SMA200-0.13% Trades Volume4,361,043 Change-1.11%
Date Action Analyst Rating Change Price Target Change
Mar-21-24Downgrade Stephens Overweight → Equal-Weight $92 → $85
Mar-06-24Initiated Barclays Overweight $101
Jan-02-24Upgrade Wells Fargo Equal Weight → Overweight $82 → $90
Sep-05-23Upgrade BofA Securities Underperform → Neutral $79 → $72
Aug-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $94 → $73
Jul-12-23Downgrade Wolfe Research Outperform → Peer Perform
Jun-20-23Initiated UBS Neutral $72
Apr-21-23Initiated Cantor Fitzgerald Overweight $80
Mar-08-23Downgrade Deutsche Bank Buy → Hold $94 → $79
Feb-23-23Downgrade JP Morgan Overweight → Neutral $94 → $90
May-01-24 12:28PM
09:50AM
Apr-30-24 11:23AM
07:19AM
07:19AM
09:45AM Loading…
Apr-29-24 09:45AM
Apr-27-24 03:04AM
01:05AM
Apr-26-24 11:26PM
01:45PM
12:11PM
11:31AM
10:53AM
09:30AM
08:54AM
07:31AM Loading…
07:31AM
07:11AM
06:26AM
06:16AM
06:14AM
06:06AM
06:00AM
Apr-24-24 12:34PM
Apr-23-24 01:36PM
09:15AM
Apr-19-24 10:00AM
Apr-16-24 12:15PM
08:30AM
Apr-15-24 05:13PM
04:17PM
09:34AM Loading…
09:34AM
04:50AM
Apr-11-24 10:50AM
05:34AM
04:00AM
Apr-09-24 04:30PM
12:47PM
Apr-08-24 05:51PM
09:40AM
07:41AM
06:36AM
Apr-02-24 04:50PM
10:00AM
07:31AM
Apr-01-24 10:32PM
11:17AM
08:40AM
Mar-30-24 06:50AM
Mar-29-24 04:28PM
Mar-27-24 08:58AM
08:00AM
Mar-26-24 06:51PM
Mar-25-24 02:30PM
Mar-18-24 10:00AM
09:58AM
09:40AM
Mar-17-24 12:55PM
Mar-14-24 08:45AM
Mar-13-24 10:13AM
Mar-12-24 06:00AM
Mar-10-24 08:29AM
Mar-07-24 12:15PM
11:31AM
06:01AM
Mar-05-24 06:03AM
Mar-04-24 09:50AM
Mar-01-24 12:23PM
Feb-29-24 04:30PM
09:00AM
Feb-28-24 08:00AM
Feb-21-24 09:40AM
09:40AM
Feb-20-24 11:00AM
10:15AM
04:03AM
Feb-16-24 01:58PM
06:03AM
Feb-15-24 11:00AM
Feb-14-24 12:45PM
07:36AM
Feb-13-24 10:00AM
Feb-11-24 08:00AM
Feb-09-24 02:21AM
Feb-08-24 09:45AM
Feb-07-24 10:50AM
Feb-06-24 11:58PM
11:49PM
01:00PM
12:30PM
12:19PM
09:30AM
07:03AM
06:35AM
06:26AM
06:23AM
06:21AM
06:17AM
06:16AM
06:08AM
06:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Robinson Lori JeanDirectorFeb 13 '24Option Exercise54.6510,000546,50021,455Feb 15 06:31 PM
Robinson Lori JeanDirectorFeb 13 '24Sale77.4110,000774,10011,455Feb 15 06:31 PM
FASOLA KENNETH JPresidentFeb 07 '24Sale75.0712,000900,817235,365Feb 08 07:38 PM